ASND icon

Ascendis Pharma A/S
ASND

Upgrade to unlock
Buy
Hold
Sell

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
Avg. target
$275
27% upside
High target

1 analyst rating

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
RBC Capital
RBC Capital
Luca Issi
80% 1-yr ASND win rate
3 Mar ‘26 3 months ago